Seeking opportunities for collaboration on the production of ATMPs in Spain

We are a biotechnology company focused on the development of innovative oncolytic virus-based therapies as advanced therapy medicinal products (ATMPs/GTMPs). Our pipeline is currently progressing through preclinical development, with a strong emphasis on safety, biodistribution, and immunological characterization.

We are seeking to establish collaborations in Spain with experienced partners in GMP manufacturing of viral-based ATMPs. Specifically, we are interested in CDMOs and specialized facilities capable of supporting process development, scale-up, GMP production, quality control, and regulatory compliance aligned with EMA/AEMPS requirements.

Our goal is to identify reliable partners to support the transition from preclinical development to early-phase clinical trials, including expertise in viral vector production, technology transfer, and CMC strategy development.

We are also open to collaborations with academic or translational centers with relevant infrastructure and expertise in advanced therapies.